The Tech Tour 2018 Digital Health and Medtech Award 

On 26th June we had the great pleasure to hand our 2018 Healthtech Awards to Tech Tour past alumni, who turned into success stories. The Tech Tour 2018 Digital Health Award went to Dan Vahdat, Medopad and the Tech Tour 2018 Medtech Award went to Timo Hercegfi, invendo medical GmbH.

 

We are delighted to be chosen as the winner of the Tech Tour 2018 Digital Health Award but we remain humble and continue to channel all our efforts in making our vision a reality – to create a world where people can live longer, a world where people can continue to do their greatest work and a world where people can continue to love their loved ones. Dan Vahdat, CEO of Medopad It’s really a huge honour to receive this award as appreciation for the hard work that eventually led to our sale to Ambu last year. invendo did not have a clean story to offer. We’ve gone through ups and downs during our history and have encountered many “near-death” experiences. But in the end it was persistence and determination that paid off. We’ve been around far longer than many other startups and I’m also grateful that we have seen so much support from our VC backers who have learnt a very valuable lesson that showing patience pays off. Great people can make it happen – and we have a lot of them. Timo Hercegfi, CEO of  invendo medical

Past Award Winners include: eDevice, Symetis, Neuravi, Mindmaze, Cequr, Occlutech, EOS, Endosense, Sapiens Steering Brain Stimulation and Sophia Genetics.

The 2018 Award celebrated excellence in entrepreneurship and successful commercialization of innovative health technology in Europe, making significant global impact in healthcare. The awards are designed to highlight the successful development of  European companies that made significant achievements since their presentation at a prior Tech Tour Healthtech or Medtech Summit or with a most impressive market traction and fundraising activity to date. 

Since its inception in 2008, the Tech Tour Healthtech Summits have profiled some of the most promising European Medtech  and Digital Health companies. To date over 600 companies have been reviewed by senior professionals on the Selection Committee and 240 companies have been selected to participate in Tech Tour Summits to date.  


Heatlhtech Summit 2018 Award Winners


The Tech Tour 2018 Digital Health Award 
 

	Medopad Medopad is a British enterprise healthcare technology company headquartered in London. KPMG recently named Medopad a $1B HealthTech company in the making. Medopad offers remote monitoring apps and data analytics that support stakeholders in ensuring treatments are aligned with best practice, improving outcomes and cost. The resulting data ecosystem provides the foundation for Medopad’s Machine Learning and precision medicine solutions that address some of the challenges of early detection of hard to detect life threatening health conditions. Medopad is CE approved, registered with the FDA and is HIPAA compliant. Primary clients are large hospital groups and pharmaceutical companies, and since 2012, Medopad has been a supplier to the NHS. Amongst its clients are: Bayer, Johnson & Johnson, Novartis, HCA (World’s largest hospital group), Barts Health (Largest NHS Trust), Royal Free (Second largest NHS Trust) and more. Its institutional investors include Bayer pharmaceutical and Bupa.
	Dan Vahdat CEO of Medopad
	Dan Vahdat is CEO of Medopad, a British healthtech company enabling connected care, headquartered in London, UK. KPMG recently named Medopad a $1B company in the making. Multiple global press outlets have written about Medopad's recent successes in China, as well as their successful fund raise to pursue AI initiatives alongside partners such as Tencent and Johns Hopkins. Dan is an award-winning innovator in the fields of science and technology. His professional career spans from IT to medical technology including several years at Johns Hopkins in the US. Dan studied Engineering and Mathematics, after which he pursued his PhD in Bio-Engineering at Johns Hopkins and Oxford University. He left his PhD to focus on the digital healthcare revolution with Medopad.

	invendo medical Medopad is a British enterprise healthcare technology company headquartered in London. KPMG recently named Medopad a $1B HealthTech company in the making. Medopad offers remote monitoring apps and data analytics that support stakeholders in ensuring treatments are aligned with best practice, improving outcomes and cost. The resulting data ecosystem provides the foundation for Medopad’s Machine Learning and precision medicine solutions that address some of the challenges of early detection of hard to detect life threatening health conditions. Medopad is CE approved, registered with the FDA and is HIPAA compliant. Primary clients are large hospital groups and pharmaceutical companies, and since 2012, Medopad has been a supplier to the NHS. Amongst its clients are: Bayer, Johnson & Johnson, Novartis, HCA (World’s largest hospital group), Barts Health (Largest NHS Trust), Royal Free (Second largest NHS Trust) and more. Its institutional investors include Bayer pharmaceutical and Bupa.
	Timo Hercegfi CEO of  invendo medical
	Mr. Hercegfi has more than 15 years of experience in management of financial operations. He spent several years as a relationship manager in the corporate banking division of Deutsche Bank AG, amongst others in charge of innovative technology companies in the biotechnology and medtech sector. In addition he was also in charge of several turnaround cases and closed numerous financing transactions. Subsequently Mr. Hercegfi joined PricewaterhouseCoopers as a management consultant, working as a project leader on a Europe-wide basis. From 2000 until January 2007 Mr. Hercegfi served as a Partner and CFO at Heidelberg Innovation, a European medical technology-focussed venture capital firm and key investor of invendo medical. From 2003 onwards he was a board member of our company and took on an operating position in February 2007 becoming invendo medical`s Chief Financial Officer (CFO). Timo Hercegfi holds a degree in business administration from the University of Cooperative Education Mosb.